Himax Technologies, Inc. (HIMX): what the price assumes
In the published model solve dated 2026-Q2, anchored at $11.40, Himax Technologies, Inc. (HIMX) is priced for today's economics sustained for ~13.6 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.
Generated: 2026-07-29 · Exported: 2026-08-01 · Source: https://boothcheck.com/report/HIMX
Headline
| Field | Value |
|---|---|
| Ticker | HIMX |
| Company | Himax Technologies, Inc. |
| Current price | $11.40/sh |
| Composition | Display drivers for large-sized applications 11% / Display drivers for small and medium-sized applications 69% / Non-driver products 20% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin (value-band context) | 14.5% |
| Operating margin today | 5.3% |
| Margin expansion (value-band) | +9.2pp |
| Must persist for | 13.6y |
| Multiple paid | 39x operating income |
The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.
Solve inputs: computed at a 12% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.3 years.
Reconcile: at the x-ray's 9.3% required return this reads ~8 years; the models below use their own rates.
How unusual the bet is: elevated
| Reference | Value |
|---|---|
| vs own history | +0.22σ |
| sustained it ~10 years at this level | 15% |
| implied end-window share | 0% |
Valuation X-Ray
Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 4.07x | 5 | expensive |
| Earnings | 1.31x | 3 | expensive |
| Relative | 1.42x | 3 | expensive |
| Growth | 1.62x | 5 | expensive |
Families that call it expensive: Asset, Growth
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.
Per-Model Detail (n=16)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $7.03 | 1.62x | yes | FCF base $0.1B, growth -10% (input: historical growth), terminal g 0.5%, WACC 9.2%, 5yr projection |
| DCF Exit Multiple | Growth | $11.06 | 1.03x | yes | Exit EV/EBITDA: 24.5x / 26.5x / 28.5x (bear / base = today's held flat / bull), 5yr |
| Relative Valuation | Relative | $8.02 | 1.42x | yes | P/E 28.58x (blended: static sector reference 22x + trailing (TTM) 44x), scenarios: 24.3x / 28.6x / 32.9x (bear / base = reference held flat / bull), EV/EBITDA 19.14x |
| Simple DDM | Growth | $9.23 | 1.24x | yes | DPS $0.37, g=5.0% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3% |
| Two-Stage DDM | Growth | $1.43 | 7.97x | yes | Stage 1: -28% for 5yr, Stage 2: 3.5% perpetual |
| Simple Excess Return | Asset | $2.80 | 4.07x | yes | BV/sh $5.17, ROE (TTM) 5.0%, ke 9.3% |
| Two-Stage Excess Return | Asset | $1.93 | 5.91x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $4.67 | 2.44x | yes | Rev $0.8B, growth -14% (input: historical growth; tapered), Terminal P/S: 2.0x / 2.4x / 2.7x (bear / base = today's held flat / bull, cap 8x) |
| Growth-Adjusted P/E | Relative | — | — | no | — |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $11.09 | 1.03x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.19B × (1−17%) / WACC 9.2% → EPV (no growth) |
| Residual Income | Asset | $1.83 | 6.23x | yes | BV $5.17 + 5yr PV of (ROE (TTM) 5.0% − Kₑ 9.3%) × BV; BV grows 3.3%/yr |
| Graham Number | Asset | $5.50 | 2.07x | yes | √(22.5 × EPS $0.26 × BVPS $5.17) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $7.40 | 1.54x | yes | EBITDA $0.07B × sector EV/EBITDA 16.0x |
| FCF Yield | Earnings | $8.71 | 1.31x | yes | FCF $119.9M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | $0.22 | 51.82x | yes | EPS $0.26 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median) |
| ROIC-Justified P/B | Asset | $3.00 | 3.80x | yes | BV $5.17 × (ROIC 5.4% / WACC 9.2%) |
| P/Sales Sector | Relative | $23.84 | 0.48x | yes | Revenue $0.83B × sector P/S 5.0x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | $2.81 | 4.06x | yes | EPS $0.26 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net cash | $257.5m |
| Net debt / NOPAT (after-tax) | -7.07x (net cash) |
| Net debt / operating income (pre-tax) | -5.84x (net cash) |
| Interest coverage | 12.6x |
| Share count CAGR (dilution) | 0.0% |
| Burning cash | no |
Bullet Takeaways
- Himax is a Taiwanese chip designer whose core display-driver business is at a cyclical low, with management explicitly calling the most recent quarter the earnings trough before a rebound.
- The price looks extremely high against trailing earnings precisely because those earnings are depressed: at the trough the multiple is over 100 times a temporarily low operating base.
- Watch the recovery and the new growth legs: Himax guided second-quarter revenue up 10% to 13% sequentially and is ramping automotive projects and wafer-level optics into the back half of 2026.
Bull Case
What a trailing-multiple model misses about Himax is timing: it is reading a cyclical semiconductor company at the bottom of its cycle and treating the trough as if it were normal. Management was explicit that the most recent quarter marks the earnings trough before a rebound, and the forward guidance backs that up: Himax guided second-quarter revenue to rise 10% to 13% sequentially with gross margin expanding to around 32% and profit per ADS more than doubling from the trough level. A static valuation built on the depressed trailing year cannot see that inflection, but the company's own guidance points directly at it.
The growth legs beyond the legacy display-driver business are where the real story sits. Large display-driver revenue grew 11.7% sequentially, outperforming guidance, and the company sees upward momentum building through 2026 from a meaningful number of new automotive design wins scheduled to enter mass production in the second half. More strategically, Himax has in-house manufacturing capacity in wafer-level optics and LCoS, the technologies that feed augmented-reality displays and advanced sensing, and it has that capacity already in place to support the strong growth it anticipates over the next few years. Those are higher-value, less-commoditized products than the small-panel drivers that make up the bulk of today's revenue, and they reframe Himax from a commodity chip vendor into an optics and automotive supplier.
The balance sheet gives the cyclical bet a floor. Himax holds about $258 million of net cash with no debt, so it can fund its automotive and optics ramp and ride out the cycle without financial stress, and the share count has been flat with no dilution. A debt-free, net-cash chip designer at the bottom of its cycle, guiding to a sharp sequential rebound and ramping genuinely new growth markets, is exactly the durable inflection the static valuation frames structurally cannot price.
Bear Case
The valuation methods do not agree on Himax, and when read carefully the disagreement favors caution. No family of standard methods reaches the current price: the asset-value, earnings-power, peer-multiple, and even forward-growth approaches all read the stock as expensive. The bull explanation is that trailing earnings are at a trough, but that argument cuts both ways. The same methods that look punitive at the bottom of the cycle were the ones that correctly flagged the stock as cheap when earnings were high, and a company whose earnings are this cyclical is one where the conservative methods deserve more weight, not less, because they smooth out exactly the volatility the bull is asking you to look through.
The core problem is that display-driver chips are a commodity. The small and medium-sized display-driver segment, which makes up the bulk of revenue, declined sequentially amid what the company called a typical low season, and that business competes on price against other Asian fabless designers with little differentiation. Gross margin around 30% is respectable for the category but reflects a business with limited pricing power, and the cyclical demand for panels in phones, TVs, and monitors is outside Himax's control. A recovery in this segment depends on the broader consumer-electronics cycle turning, which no design win can guarantee.
The newer growth areas are real but unproven at scale and lumpy. Non-driver sales, which include the automotive Tcon and ASIC products the bull case leans on, fell 7.7% sequentially as shipments to a leading projector customer declined and automotive Tcon demand moderated after several strong quarters. That is the risk in a nutshell: the diversification segments are still small enough that a single customer's order timing swings them, and the wafer-level optics opportunity tied to augmented reality has been a few years away for several years running. A company priced for decades of sustained growth, whose largest business is a commodity at a cyclical low and whose growth legs remain customer-concentrated and back-end loaded, is a demanding bet at a triple-digit trough multiple.
Valuation
At about $18 (June 27, 2026) Himax trades at well over 100 times trailing company-wide operating income, a multiple that looks absurd until you recognize the denominator is a cyclical trough. Management has called the most recent quarter the earnings low before a rebound, so the trailing operating profit understates the business; the headline multiple is a function of depressed earnings, not an extreme price relative to normalized power. Read against the cyclical reality, the question is how quickly and how far the recovery comes, not whether the stock is priced at a literal hundred-times multiple of sustainable profit.
That said, the methods are unanimous that the stock is not cheap on any current measure. No valuation family reaches the price: asset value, earnings power, peer multiples, and forward growth all sit below it. Even allowing for the trough, that unanimity is a caution flag. The peer-multiple read blends a sector P/E near 22 times against a trailing figure inflated by the low earnings, and the asset-based methods value the stock at many times its modest book value. The honest framing is that the price already credits a substantial cyclical recovery and a meaningful contribution from the automotive and optics growth legs; a buyer is paying today for earnings the company has not yet rebuilt.
The balance sheet is the unambiguous strength and the reason the downside is bounded. Himax holds roughly $258 million of net cash with no debt, comfortable interest coverage, and a flat share count, so it can fund its growth initiatives and survive a prolonged downturn without dilution or distress. The net-cash position is the floor under the bet: it tells you the company endures the cycle, not that the price is justified. What a buyer underwrites at this price is the speed and durability of the earnings recovery plus the scaling of the automotive and wafer-level-optics businesses, with the cash cushion ensuring Himax can wait for both to arrive.
Catalysts
Himax reported a trough quarter to open 2026, which management framed as the earnings low before a rebound. First-quarter revenue was $199.0 million, down 2.0% sequentially but at the high end of guidance, with gross margin of 30.4% and profit of 4.6 cents per diluted ADS, ahead of the guided 2.0 to 4.0 cents. Within the mix, large display-driver revenue rose 11.7% sequentially to $24.2 million, the small and medium-sized segment slipped 2.4% amid a seasonal low, and non-driver sales fell 7.7% to $39.0 million on lower projector ASIC and automotive Tcon shipments.
The forward guidance is the catalyst. Himax expects second-quarter revenue to increase 10.0% to 13.0% sequentially, gross margin around 32%, and profit per diluted ADS of 8.6 to 10.3 cents, roughly double the trough quarter. That sequential step is the company's signal that the rebound is underway.
The structural catalysts to watch are the new automotive design wins scheduled to enter mass production in the second half of 2026, which Himax expects to drive upward momentum, and the ramp of its wafer-level optics and LCoS capacity tied to augmented reality and advanced sensing. The broader consumer-electronics and panel demand cycle remains the external variable with the most leverage on the core display-driver business.
Peer Cohorts (Per Segment, With Filing Citations)
Core business (reported)
- CRUS (Cirrus Logic, Inc.)
- FY2025 10-K: …deposits or if a depository institution is subject to other adverse conditions in the financial or credit markets, there is no guarantee that we have access to such uninsured deposits, which could restrict access to our cash or cash equivalents and could adversely impact our operating liquidity, financial condition,…
- FY2025 10-K: …ability to compete effectively and to expand our business will depend on our ability to continue to recruit key engineering talent, execute on new product developments, partner with customers to create compelling products for their applications and provide cost efficient versions of existing products. We compete with…
- SYNA (SYNAPTICS INCORPORATED)
- FY2025 10-K: …competitive solutions, and ongoing technology shifts. If these markets experience slower than expected growth or if demand for our solutions weakens, our revenue and profitability could be materially impacted. Changes to international trade policies, export controls, and foreign operations expose us to legal,…
- FY2025 10-K: , including China. Our current operations suggest limited tariff exposure given our current import and export practices. However, some of our customers and suppliers may be impacted by evolving tariff regimes depending on their own supply chain strategies and sourcing locations. We continue to monitor for any…
- QRVO (Qorvo, Inc.)
- FY2025 10-K: …affect our operating results through lower prices for our products, reduced demand for our products, losses of existing design slots with key customers and a corresponding reduction in our ability to recover development, engineering and manufacturing costs. For example, due to lower profitability from increased…
- FY2025 10-K: …by rapid advances in technology and new product introductions. Our customers' product life cycles can be short, especially in mobile devices, and our competitiveness depends on our ability to improve our products and processes faster than our competitors, anticipate changing customer requirements and successfully…
- SWKS (SKYWORKS SOLUTIONS, INC.)
- FY2025 10-K: …Also, this competition has resulted in, and is expected to continue to result in, declining average selling prices for many of our products and increased challenges in maintaining or increasing revenue, gross margin, and market share. Furthermore, additional competitors may enter our markets as a result of growth…
- FY2025 10-K: …future business activities. Uncertainty and economic weakness could result in a market contraction and, as a result, our business, results of operations, and financial condition would likely be materially and adversely affected. Such periods of industry downturn are characterized by diminished product demand and…
- NXPI (NXP Semiconductors N.V.)
- FY2025 10-K: …during development, potentially rendering our products outdated or noncompetitive before their introduction. If we are unable to successfully develop new products, our revenue may decline substantially. Moreover, some of our competitors are well-established entities, are larger than us and have greater resources than…
- FY2025 10-K: …current or expected future demand is strong and margins are, or are expected to be, high. Investments in new capacity 16 can result in overcapacity, which can lead to a reduction in prices and margins. In response, companies typically limit further capacity additions, eventually causing the market to be relatively…
- ON (ON Semiconductor Corporation)
- FY2025 10-K: …materially adversely affected. The semiconductor industry is highly competitive, and has experienced significant consolidation, and if we are unable to compete effectively or identify attractive opportunities for consolidation, it could materially adversely affect our business and results of operations. Our ability…
- FY2025 10-K: …customer sales and technical support, our sales and revenue may be materially adversely affected. Competitive pressures may limit our ability to raise prices, and any inability to maintain revenue or raise prices to offset increases in costs could have a significant adverse effect on our gross margin. Our gross…
- SITM (SITIME Corp)
- FY2025 10-K: …to maintain the level of investment in research and development required to remain competitive. In addition, we cannot assure you that the technologies, which are the focus of our research and development expenditures, will become commercially successful or generate any revenue. If we fail to compete effectively, we…
- FY2025 10-K: …fluctuations in product supply and demand. From time to time, these factors, together with changes in macroeconomic conditions, can cause significant upturns and downturns in the semiconductor industry, and in our business. Downturns in the semiconductor industry have been characterized by diminished product demand,…
- SLAB (SILICON LABORATORIES INC.)
- FY2025 10-K: …in our backlog are subject to changes in delivery schedules or cancellation at the option of the purchaser, typically without penalty. Our backlog may fluctuate significantly depending upon customer order patterns which may, in turn, vary considerably based on rapidly changing business circumstances. Accordingly, we…
- FY2025 10-K: …condition • Our business, financial condition, and results of operations could be materially and adversely affected by global or industry-specific shortages of memory components or other key components necessary for our customers' products • Competition within the numerous markets we target may reduce sales of our…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
HIMX Q1 2026 results, May 2026